Sareum (SAR) Competitors GBX 17 -1.50 (-8.10%) As of 11:43 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock SAR vs. CHI, PHD, NMT, IGR, FEN, CGO, TSI, MYN, IDE, and EVGShould you be buying Sareum stock or one of its competitors? The main competitors of Sareum include CT UK High Income Trust (CHI), Proactis (PHD), Neometals (NMT), IG Design Group (IGR), Frenkel Topping Group (FEN), Contango (CGO), Two Shields Investments Plc (TSI.L) (TSI), Mayan Energy (MYN), IDE Group (IDE), and Evgen Pharma (EVG). These companies are all part of the "financial services" industry. Sareum vs. CT UK High Income Trust Proactis Neometals IG Design Group Frenkel Topping Group Contango Two Shields Investments Plc (TSI.L) Mayan Energy IDE Group Evgen Pharma Sareum (LON:SAR) and CT UK High Income Trust (LON:CHI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, community ranking, institutional ownership, risk, earnings, media sentiment, dividends and valuation. Do insiders and institutionals believe in SAR or CHI? 51.6% of CT UK High Income Trust shares are owned by institutional investors. 5.0% of Sareum shares are owned by company insiders. Comparatively, 23.4% of CT UK High Income Trust shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor SAR or CHI? Sareum received 82 more outperform votes than CT UK High Income Trust when rated by MarketBeat users. CompanyUnderperformOutperformSareumOutperform Votes8266.13% Underperform Votes4233.87% CT UK High Income TrustN/AN/A Which has more risk & volatility, SAR or CHI? Sareum has a beta of -1.08, meaning that its share price is 208% less volatile than the S&P 500. Comparatively, CT UK High Income Trust has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500. Is SAR or CHI more profitable? CT UK High Income Trust has a net margin of 84.52% compared to Sareum's net margin of 0.00%. CT UK High Income Trust's return on equity of 10.59% beat Sareum's return on equity.Company Net Margins Return on Equity Return on Assets SareumN/A -270.25% -113.80% CT UK High Income Trust 84.52%10.59%6.32% Does the media favor SAR or CHI? In the previous week, Sareum's average media sentiment score of 0.00 equaled CT UK High Income Trust'saverage media sentiment score. Company Overall Sentiment Sareum Neutral CT UK High Income Trust Neutral Which has better earnings and valuation, SAR or CHI? CT UK High Income Trust has higher revenue and earnings than Sareum. Sareum is trading at a lower price-to-earnings ratio than CT UK High Income Trust, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSareumN/AN/A-£5.28M-£4.22-4.03CT UK High Income Trust£13.28M6.12£11.22M£0.10975.00 SummaryCT UK High Income Trust beats Sareum on 10 of the 11 factors compared between the two stocks. Remove Ads Get Sareum News Delivered to You Automatically Sign up to receive the latest news and ratings for SAR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SAR vs. The Competition Export to ExcelMetricSareumBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£21.24M£117.04M£5.30B£2.47BDividend Yield1.10%3.69%5.11%4.95%P/E Ratio-4.033.0321.71129.48Price / SalesN/A4,026.68378.30231,299.36Price / Cash11.3213.0138.1527.98Price / Book6.5133.336.434.45Net Income-£5.28M-£87.82M£3.20B£5.80B7 Day Performance-6.84%2.94%4.86%3.14%1 Month Performance34.82%-6.45%-9.80%3.83%1 Year Performance-17.07%84.63%10.77%102.57% Sareum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SARSareumN/AGBX 17-8.1%N/A+7.5%£21.24MN/A-4.033,211High Trading VolumeCHICT UK High Income TrustN/AGBX 96.99+4.8%N/A+12.1%£80.81M£13.28M969.85N/ADividend AnnouncementGap UpHigh Trading VolumePHDProactisN/AN/AN/AN/A£70.69M£48.90M-3.57516NMTNeometalsN/AN/AN/AN/A£57.39MN/A-1.87N/AIGRIG Design Group3.3276 of 5 starsGBX 52+2.0%GBX 270+419.2%-56.7%£51.03M£655.48M1.763,092News CoverageFENFrenkel Topping GroupN/AGBX 33+1.5%N/A-35.6%£40.43M£34.56M38.45307CGOContangoN/AGBX 0.86+1.2%N/A-4.3%£6.22MN/A-86.002,219Gap DownTSITwo Shields Investments Plc (TSI.L)N/AN/AN/AN/A£6.15MN/A-1.053MYNMayan EnergyN/AN/AN/AN/A£5.28M£-3,000.00-0.235Gap UpIDEIDE GroupN/AN/AN/AN/A£3.60M£13.64M-18.13237EVGEvgen PharmaN/AN/AN/AN/A£3.42MN/A-80.0010 Remove Ads Related Companies and Tools Related Companies CT UK High Income Trust Competitors Proactis Competitors Neometals Competitors IG Design Group Competitors Frenkel Topping Group Competitors Contango Competitors Two Shields Investments Plc (TSI.L) Competitors Mayan Energy Competitors IDE Group Competitors Evgen Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SAR) was last updated on 4/17/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sareum Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Sareum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SAR Stock Free SAR Stock Alerts